AKT1 NP_001014431.1:p.E17K

Preferred Label : AKT1 NP_001014431.1:p.E17K;

NCIt synonyms : RAC-alpha Serine/Threonine-Protein Kinase p.Glu17Lys; AKT1 p.Glu17Lys; AKT1 NP_001014431.1:p.Glu17Lys; AKT1 Glu17Lys; AKT1 p.E17K; RAC-alpha Serine/Threonine-Protein Kinase E17K; AKT1 E17K; RAC-alpha Serine/Threonine-Protein Kinase Glu17Lys; RAC-alpha Serine/Threonine-Protein Kinase p.E17K; NP_001014431.1:p.Glu17Lys; AKT1 E17K (G49A) Mutation; AKT1 E17K Mutation;

NCIt definition : A change in the amino acid residue at position 17 in the RAC-alpha serine/threonine-protein kinase protein where glutamic acid has been replaced by lysine.;

Détails

Origin ID

C98306;

UMLS CUI

C3273954;

Semantic type(s)
- Cell or Molecular Dysfunction [UMLS semantic type]
concept_is_in_subset
- CTRP Biomarker Terminology [NCIt concept]
- CTRP Molecular Genetic Biomarker Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
gene_product_sequence_variation_encoded_by_gene_mutant
- AKT1 Gene Mutation [NCIt concept]
- AKT1 NM_001014431.1:c.49G>A [NCIt concept]
gene_product_variant_of_gene_product
- RAC-Alpha Serine/Threonine Kinase [NCIt concept]
is_molecular_abnormality_of_disease
- Salivary Gland Mucinous Adenocarcinoma [NCIt concept]
is_target
- AKT1 E17K Inhibitor ALTA2618 [NCIt concept]
molecular_abnormality_involves_gene
- AKT1 Gene [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients